Potential role of nuclear PD-L1 expression in cell-surface vimentin positive circulating tumor cells as a prognostic marker in cancer patients
Arun Satelli(The University of Texas MD Anderson Cancer Center), Shulin Li(The University of Texas MD Anderson Cancer Center)
Cited by 195
Related Papers
EMT, CTCs and CSCs in tumor relapse and drug-resistance
|Oncotarget|2015|464
FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation
|Nature Communications|2019|119
WSX1 act as a tumor suppressor in hepatocellular carcinoma by downregulating neoplastic PD-L1 expression
|Nature Communications|2021|56
Immune checkpoint regulator PD-L1 expression on tumor cells by contacting CD11b positive bone marrow derived stromal cells
|Cell Communication and Signaling|2015|54